缩写名/全名 |
CANCER IMMUNOL IMMUN
CANCER IMMUNOLOGY IMMUNOTHERAPY |
||||||||||||||||||||||||||||
ISSN号 | 0340-7004 | ||||||||||||||||||||||||||||
研究方向 | 医学-免疫学 | ||||||||||||||||||||||||||||
影响因子 | 2015:4.846, 2016:4.711, 2017:4.225, 2018:4.9, 2019:5.442, | ||||||||||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||||||||||
年文章数 | 160 | ||||||||||||||||||||||||||||
出版年份 | 0 | ||||||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||||||
审稿周期(仅供参考) | 平均1月 |
||||||||||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||||||||||
投稿链接 | https://www.editorialmanager.com/ciim/default.aspx | ||||||||||||||||||||||||||||
投稿官网 | http://www.springer.com/medicine/internal/journal/262 | ||||||||||||||||||||||||||||
h-index | 104 | ||||||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0340-7004%5BISSN%5D | ||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma Author: Ying Xiong, Li Liu, Yu Xia, Yangyang Qi, Yifan Chen, Lingli Chen, Peipei Zhang, Yunyi Kong, Yang Qu, Zewei Wang, Zhiyuan Lin, Xiang Chen, Zhuoyi Xiang, Jiajun Wang, Qi Bai, Weijuan Zhang, Yuanfeng Yang, Jianming Guo, Jiejie Xu Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, Vol., , DOI:10.1007/s00262-019-02314-y DOI |
2. | Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer Author: Rui Zhou, Jingwen Zhang, Dongqiang Zeng, Huiying Sun, Xiaoxiang Rong, Min Shi, Jianping Bin, Yulin Liao, Wangjun Liao Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, Vol., , DOI:10.1007/s00262-018-2289-7 DOI |
3. | CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions Author: Wanghong Hu, Zhenguo Zi, Yanling Jin, Gaoxin Li, Kang Shao, Qiliang Cai, Xiaojing Ma, Fang Wei Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, Vol., , DOI:10.1007/s00262-018-2281-2 DOI |
4. | The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma Author: Boyang Chang, Tao Huang, Huajun Wei, Lujun Shen, Duo Zhu, Wenjun He, Qifeng Chen, Huihua Zhang, Yunjian Li, Ruopan Huang, Wang Li, Peihong Wu Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, Vol., , DOI:10.1007/s00262-018-2271-4 DOI |
5. | Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma Author: Wei Wang, Wai-Ching Lam, Ling Chen Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, Vol.68, 85-95, DOI:10.1007/s00262-018-2260-7 DOI |
6. | Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer Author: Wen Zhang, Xu Lu, Peilin Cui, Chunmei Piao, Man Xiao, Xuesong Liu, Yue Wang, Xuan Wu, Jingwei Liu, Lin Yang Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, Vol.68, 121-130, DOI:10.1007/s00262-018-2257-2 DOI |
7. | Higher numbers of T-bet<Superscript>+</Superscript> intratumoral lymphoid cells correlate with better survival in gastric cancer Author: Lu-jun Chen, Xiao Zheng, Yue-ping Shen, Yi-bei Zhu, Qing Li, Junjun Chen, Rui Xia, Shu-ming Zhou, Chang-ping Wu, Xue-guang Zhang, Bin-feng Lu, Jing-ting Jiang Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, Vol.62, 553-561, DOI:10.1007/s00262-012-1358-6 DOI |
8. | Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance Author: Xiao-wei Zhang, Xia Qin, Crystal Y. Qin, Yu-lei Yin, Yan Chen, Hui-li Zhu Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, Vol.62, 563-570, DOI:10.1007/s00262-012-1361-y DOI |
9. | The antitumor effect of the Toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant Author: Yu-Kun Huang, Zhi Zheng, Chun-Xia Cheng, Lu-Ying Wang, Yue-Ran Li, Fu Qiu Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, Vol.62, 237-244, DOI:10.1007/s00262-012-1328-z DOI |
10. | The immunogenicity of a novel cytotoxic T lymphocyte epitope from tumor antigen PL2L60 could be enhanced by 4-chlorophenylalanine substitution at position 1 Author: Ran-ran Shi, Jing Liu, Zhe Zou, Yuan-ming Qi, Ming-xia Zhai, Wen-jie Zhai, Yan-feng Gao Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, Vol.62, 1723-1732, DOI:10.1007/s00262-013-1478-7 DOI |
|
|